Business Context and Reporting Period
Company: Denali Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 2, 2018
Event: Entry into a Material Definitive Agreement (First Amendment to Lease).
Key Financial Metrics and Obligations
This filing details a lease amendment rather than operational financial performance. Key financial terms include:
- Lease Term: Extended by ten years from commencement (later of Feb 1, 2019, or occupancy), with one 10-year option to extend.
- Base Rent: Approximately $0.4 million/month for the first six months; increasing to $0.7 million/month in month 7; $0.8 million/month after the first year.
- Rent Escalation: 3.5% annual increases thereafter, reaching approximately $12.5 million in the final year.
- Security: Letter of credit increased to $1.5 million.
- Tenant Improvements: Landlord allowance of approximately $21.5 million; additional allowance of approximately $4.4 million repayable as additional rent.
Note: The filing does not provide revenue, profit, cash flow, margins, or total debt figures.
Material Changes
The Company amended its existing lease (dated September 24, 2015) for approximately 38,109 square feet at 151 Oyster Point Blvd. The amendment substitutes this space with approximately 148,020 rentable square feet at a new "Replacement Premises" located at 161 Oyster Point Blvd., South San Francisco, California, upon readiness for occupancy.
Outlook, Risks, and Contingencies
- Construction Contingency: The lease commencement and rent obligations are contingent on the Replacement Premises being ready for occupancy.
- Cost Allocation: The Landlord will fund the "warm shell" improvements, while the Company is responsible for the remainder, subject to the allowances noted above.
- Disclosure: The full text of the Lease Amendment will be filed as an exhibit to the Form 10-Q for the quarter ending June 30, 2018.
Investor Verification Checklist
- Verify the actual commencement date of the lease relative to the "ready for occupancy" status of the new building.
- Confirm the total capital expenditure required by the Company for tenant improvements after applying the $21.5 million allowance.
- Review the upcoming Form 10-Q (Q2 2018) for the full legal text of the Lease Amendment.
- Assess the impact of the increased letter of credit ($1.5 million) on the Company's available liquidity.